Medmira ( (TSE:MIR)) has shared an update. MedMira reported first-quarter fiscal 2026 results marked by Health Canada approval of its Reveal TP rapid syphilis antibody test, enabling nationwide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results